JP2012514994A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012514994A5 JP2012514994A5 JP2011545794A JP2011545794A JP2012514994A5 JP 2012514994 A5 JP2012514994 A5 JP 2012514994A5 JP 2011545794 A JP2011545794 A JP 2011545794A JP 2011545794 A JP2011545794 A JP 2011545794A JP 2012514994 A5 JP2012514994 A5 JP 2012514994A5
- Authority
- JP
- Japan
- Prior art keywords
- coding rna
- expression
- intervention
- interventions
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0900809A GB0900809D0 (en) | 2009-01-19 | 2009-01-19 | Methods employing non-coding RNA expression assays |
| GB0900809.5 | 2009-01-19 | ||
| GB0917708.0 | 2009-10-09 | ||
| GB0917708A GB0917708D0 (en) | 2009-10-09 | 2009-10-09 | Methods employing non-coding rna expression assays |
| PCT/GB2010/000076 WO2010082039A1 (en) | 2009-01-19 | 2010-01-19 | Methods employing non-coding rna expression assays |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012514994A JP2012514994A (ja) | 2012-07-05 |
| JP2012514994A5 true JP2012514994A5 (cg-RX-API-DMAC7.html) | 2013-03-07 |
Family
ID=42078007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011545794A Pending JP2012514994A (ja) | 2009-01-19 | 2010-01-19 | 非コードrna発現アッセイを用いた方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9074241B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2387617B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012514994A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20110138341A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102356163A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010205493A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2787218A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL214154A (cg-RX-API-DMAC7.html) |
| SG (2) | SG173042A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010082039A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201014049D0 (en) * | 2010-08-23 | 2010-10-06 | Sistemic Uk | Cell characterisation |
| CN108319814B (zh) * | 2018-01-29 | 2018-12-14 | 中国科学院生物物理研究所 | 基于染色体空间相互作用预测长非编码rna生物学功能的方法 |
| CN111899788B (zh) * | 2020-07-06 | 2023-08-18 | 李霞 | 一种非编码rna调控疾病风险靶通路的识别方法及系统 |
| CN113593700B (zh) * | 2021-08-06 | 2024-02-27 | 江苏师范大学 | 分析肺癌进展的方法、装置、设备、介质及程序产品 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU773456B2 (en) * | 1998-10-27 | 2004-05-27 | Rosetta Inpharmatics Llc | Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| WO2005056761A2 (en) | 2003-12-05 | 2005-06-23 | Massachusetts Institute Of Technology | REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| DK1735459T3 (da) * | 2004-04-07 | 2012-05-29 | Exiqon As | Fremgangsmåder til kvantificering af microRNA'er og små interfererende RNA'er |
| WO2008095096A2 (en) * | 2007-01-31 | 2008-08-07 | Immune Disease Institute | Let-7 microrna and mimetics thereof as therapeutics for cancer |
| AU2008231393A1 (en) | 2007-03-27 | 2008-10-02 | Rosetta Genomics Ltd. | Gene expression signature for classification of cancers |
| WO2008154098A2 (en) * | 2007-06-07 | 2008-12-18 | Wisconsin Alumni Research Foundation | Reagents and methods for mirna expression analysis and identification of cancer biomarkers |
| WO2009015071A1 (en) * | 2007-07-23 | 2009-01-29 | Dharmacon, Inc. | Screening of micro-rna cluster inhibitor pools |
| GB2459228B (en) * | 2007-07-25 | 2012-06-20 | Univ Louisville Res Found | Exosome-associated microrna as a diagnostic marker |
| EP2225396A4 (en) * | 2007-11-30 | 2011-03-02 | Univ Ohio State Res Found | PROFILING AND SCREENING OF MICRO-RNA EXPRESSION IN PERIPHERAL BLOOD IN LUNG CANCER |
-
2010
- 2010-01-19 CN CN2010800129012A patent/CN102356163A/zh active Pending
- 2010-01-19 EP EP10705399.3A patent/EP2387617B1/en active Active
- 2010-01-19 WO PCT/GB2010/000076 patent/WO2010082039A1/en not_active Ceased
- 2010-01-19 AU AU2010205493A patent/AU2010205493A1/en not_active Abandoned
- 2010-01-19 SG SG2011052065A patent/SG173042A1/en unknown
- 2010-01-19 CA CA2787218A patent/CA2787218A1/en not_active Abandoned
- 2010-01-19 EP EP12169171.1A patent/EP2492357B1/en active Active
- 2010-01-19 US US13/145,208 patent/US9074241B2/en active Active
- 2010-01-19 JP JP2011545794A patent/JP2012514994A/ja active Pending
- 2010-01-19 SG SG2014004279A patent/SG196843A1/en unknown
- 2010-01-19 KR KR1020117019196A patent/KR20110138341A/ko not_active Withdrawn
-
2011
- 2011-07-18 IL IL214154A patent/IL214154A/en active IP Right Grant
-
2015
- 2015-07-06 US US14/792,057 patent/US20160002722A1/en not_active Abandoned
-
2016
- 2016-11-11 US US15/349,554 patent/US20170058346A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zangrando et al. | Identification of candidate long non-coding RNAs in response to myocardial infarction | |
| Johansson et al. | A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests | |
| van der Veen et al. | Applicability of a keratinocyte gene signature to predict skin sensitizing potential | |
| US20200309767A1 (en) | High-throughput imaging-based methods for predicting cell-type-specific toxicity of xenobiotics with diverse chemical structures | |
| Wargodsky et al. | RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections | |
| Abedini et al. | Spatially resolved human kidney multi-omics single cell atlas highlights the key role of the fibrotic microenvironment in kidney disease progression | |
| WO2007130831A3 (en) | Methods and apparatus for identifying disease status using biomarkers | |
| Dybas et al. | Integrative proteomics reveals an increase in non-degradative ubiquitylation in activated CD4+ T cells | |
| JP2015514227A (ja) | 結核バイオマーカーおよびその使用 | |
| CN110392740A (zh) | 确定人群样本生物指标集、预测生物学年龄的方法及其应用 | |
| CA2795554A1 (en) | Gene-expression profiling with reduced numbers of transcript measurements | |
| EP4220646A8 (en) | Basal culture medium development method, basal culture medium formulation and development, and system thereof | |
| JP2016073287A (ja) | 腫瘍特性及びマーカーセットの同定のための方法、腫瘍分類、並びに癌のマーカーセット | |
| Chikina et al. | Low‐variance RNAs identify Parkinson's disease molecular signature in blood | |
| Field et al. | Urinary biomarkers of acute kidney injury in deceased organ donors–kidney injury molecule‐1 as an adjunct to predicting outcome | |
| MX2020010825A (es) | Sistema y metodo para determinar la salud pulmonar. | |
| van der Veen et al. | Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: Analysis of existing data | |
| US12505549B1 (en) | Microscopy image analyses for disease modeling | |
| Zeljkovic et al. | The prospect of genomic, transcriptomic, epigenetic and metabolomic biomarkers for the personalized prevention of type 2 diabetes and cardiovascular diseases | |
| Rezapour et al. | Assessing concordance between RNA-Seq and NanoString technologies in Ebola-infected nonhuman primates using machine learning | |
| Bianchi et al. | Detailed regulatory interaction map of the human heart facilitates gene discovery for cardiovascular disease | |
| Zahariev et al. | Cluster oligonucleotide signatures for rapid identification by sequencing | |
| Han et al. | Low testing rates limit the ability of genomic surveillance programs to monitor SARS-CoV-2 variants: a mathematical modelling study | |
| Stein et al. | Spatial and single-cell transcriptomics reveal programs governing fibroblastic foci fibroblasts | |
| Hawtin et al. | Immune monitoring technology primer: single cell network profiling (SCNP) |